82_FR_16902 82 FR 16837 - Proposed Data Collection Submitted for Public Comment and Recommendations

82 FR 16837 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 65 (April 6, 2017)

Page Range16837-16839
FR Document2017-06864

The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on Zika virus persistence in body fluids of patients with Zika virus infection in Puerto Rico (ZIPER Study) to fill gaps in the scientific knowledge base for ZIKV regarding the persistence and transmissibility of ZIKV in body fluids. This information assist ongoing public health response activities, as well as advance the scientific understanding of ZIKV illness and transmission.

Federal Register, Volume 82 Issue 65 (Thursday, April 6, 2017) 
[Federal Register Volume 82, Number 65 (Thursday, April 6, 2017)]
[Notices]
[Pages 16837-16839]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-06864]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-17-1140; Docket No. CDC-2017-0030]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on Zika virus 
persistence in body fluids of patients with Zika virus infection in 
Puerto Rico (ZIPER Study) to fill gaps in the scientific knowledge base 
for ZIKV regarding the persistence and transmissibility of ZIKV in body 
fluids. This information assist ongoing public health response 
activities, as well as advance the scientific understanding of ZIKV 
illness and transmission.

DATES: Written comments must be received on or before June 5, 2017.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0030 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying

[[Page 16838]]

information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information.

Proposed Project

    Zika virus persistence in body fluids of patients with Zika virus 
infection in Puerto Rico (ZIPER Study)--Revision--National Center for 
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC plans to seek a one-year OMB approval to extend information 
collection covered under OMB Control Number 0920-1140, expiration date 
10/31/2017.
    The Zika PERsistence (ZIPER) study will help inform the presence 
and duration of Zika virus (ZIKV) shedding in several body fluids among 
RT-PCR-positive ZIKV cases from Puerto Rico. It will also provide 
information regarding the duration of detection of anti-ZIKV 
Immunoglobulin M (IgM) antibodies and the time for development of 
Immunoglobulin G (IgG) antibodies among the same population. In 
addition, this study will determine the prevalence of anti-ZIKV IgM and 
IgG, and virus shedding in body fluids among household contacts of ZIKV 
cases.
    We propose to investigate the persistence (shedding) of ZIKV in 
different body fluids and its relation to immune response to provide a 
basis for development of non-blood-based diagnostic tools, and target 
and refine public health interventions to arrest ongoing spread of 
infection. To do so, we will conduct a prospective cohort study of 
individuals with reverse transcription-polymerase chain reaction (RT-
PCR) positive ZIKV infection and a cross-sectional study of their 
household contacts. Results and analyses will be used to update 
relevant counseling messages and recommendations from the CDC.
    The study will include baseline and follow-up questionnaires and 
the collection of the following specimens: blood, saliva, urine from 
participants of all ages, and semen/vaginal secretions from adults 
(ages 21 years or older) and legally emancipated minors (support 
themselves financially, live independent of their parents, are 
pregnant, or have children). Individuals with RT-PCR positive ZIKV 
infection will be recruited through the Sentinel Enhanced Dengue 
Surveillance System (SEDSS) at Saint Luke's Episcopal Hospital in 
Ponce, Puerto Rico and through passive surveillance in selected 
municipalities in Puerto Rico. SEDSS was established in 2012 through a 
cooperative agreement between the hospital in Consortium with the Ponce 
School of Medicine and Ponce Research Institute from the Ponce Health 
Sciences University and the CDC (Protocol #6214). Specimens will be 
tested for the presence of ZIKV ribonucleic acid (RNA) by RT-PCR at the 
CDC Dengue Branch Laboratory in San Juan, and positive specimens will 
be further tested for virus isolation to evaluate infectivity. Each 
body fluid will be collected on a weekly basis for 4 weeks and biweekly 
thereafter until two consecutive negative RT-PCR results are obtained 
from all specimens. Irrespective of RNA detection, body fluids will 
also be collected for RT-PCT at 2, 4, and 6 months to investigate 
intermittent shedding. Analyses of antibody response through titers of 
IgM and IgG will be performed at baseline and repeated at 2, 4, and 6 
months. Among symptomatic participants seven milliliters (ml) of blood 
will be drawn at each study visit split into a tiger top tube (5ml) and 
a purple top tube (2ml) for a total not to exceed 50 ml during any 
given 8-week period. At enrollment healthy non-pregnant adults will 
have 20 ml of blood collected following standard procedures. Two tiger 
top tubes of 8.5 ml and one 3ml purple top tubes will be collected. 
These procedures will be repeated at each follow-up visit, see below. 
RT-PCR-positive participants will be asked to refer up to 5 household 
members to establish the percentage of household members with 
detectable and potentially infectious Zika virus RNA in body fluids. 
Household members who are found to be ZIKV RT-PCR-positive in any body 
fluid will be invited to participate in the cohort study. A second 
study visit will be scheduled with household contact at 2 or 4 months, 
to detect new infections and estimate incidence. Because the original 
study consent forms do not include this visit, household contacts will 
be contacted by study staff and will be consented again using the same 
consent form.
    Since receipt of the initial OMB information collection approval in 
October 2016, the project has enrolled 295 Zika virus-infected 
individuals into the Zika virus Persistence study, which are 55 
individuals below the target enrollment of 350 individuals. 
Nonetheless, preliminary findings have been published in New England 
Journal of Medicine, where we also expect that the final report that 
includes the full sample size will be published.
    This is a request to continue information collection with minor 
modifications. Modifications have been made to reflect the developing 
nature of the science surrounding Zika virus infection and potential 
outcomes associated with infection, as well as additional questions 
that were best answered by taking advantage of the existing study 
platform. Specifically, CDC proposes the addition of two components to 
the collection of data under this study, one of which has already 
begun:

    1. A follow-up household visit has been added to determine how many 
household members of Zika virus-infected participants become infected 
during the 4 months following initial screening. For any household 
members that had no evidence of Zika virus infection at the initial 
visit, the same questionnaires used at the initial household visit will 
again be completed ~4 months later. Such information will provide 
additional information regarding the incidence of Zika virus infections 
among households with a Zika-positive household member.
    2. Additionally, CDC proposes following up with men with Zika 
virus-positive semen specimens to better understand the effect of Zika 
virus infection on sperm. To do this, 8-14 semen ejaculates from 10-20 
men participating in the ZIPER study will be used to determine the 
presence and/or detection of the Zika virus in different fractions of 
the semen ejaculate (i.e., seminal plasma, cellular debris, including 
White Blood Cells [WBCs] and spermatozoa). CDC's Institutional Review 
Board (IRB) has approved this modification, but information collection 
has not begun.

    There is no cost to respondents other than the time to participate.
    Authorizing legislation comes from Section 301 of the Public Health 
Service Act (42 U.S.C. 241).

[[Page 16839]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of        Average
      Type of respondents           Form name        Number of     responses per    burden per     Total burden
                                                    respondents     respondent    response (hrs)       (hrs)
----------------------------------------------------------------------------------------------------------------
Public health personnel.......  Shedding                      55               8           10/60              74
                                 Questionnaire
                                 (Symptomatics).
                                Shedding                     100               1           10/60              17
                                 Questionnaire
                                 (Cross-
                                 Sectional
                                 Asymptomatics).
                                Questionnaire                 30               1           20/60              10
                                 for men semen
                                 sub-study.
General public................  Shedding                     160               1            2/60               6
                                 Eligibility
                                 Form.
                                Contact                       32               1            2/60               1
                                 Information
                                 Form.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             108
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-06864 Filed 4-5-17; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 82, No. 65 / Thursday, April 6, 2017 / Notices 16837 who drive a company vehicle will also additional minutes to complete for those Comments submitted in response to be asked to complete ‘‘Module 4: Motor using the tablet (approximately 168 this notice will be reviewed and Vehicle.’’ An estimated 75% of the workers per year) as well as 5 minutes addressed prior to OMB application workers will complete the driving for those completing the hardcopy submission. The total estimated burden portion of the survey (187 workers). version (19 workers per year). hours are 151. This module will take approximately 5 ESTIMATED ANNUALIZED BURDEN HOURS Average Number of Type of Number of burden per Form name responses per respondents respondents response respondent (in hours) Screening of Workers ........................................ Module 1: Screening ......................................... 313 1 5/60 O&G Extraction Workers ................................... Non Respondent Questionnaire ....................... 63 1 5/60 O&G Extraction Workers ................................... Tablet Version, Modules 2: General, Module 3: 225 1 25/60 Well Site Work, and, Module 5: Closing Questions. O&G Extraction Workers ................................... Hardcopy, Version, Modules 2: General, Mod- 25 1 25/60 ule 3: Well Site Work, and, Module 5: Clos- ing Questions. O&G Extraction Workers who drive at work ..... Tablet Version, Module 4: Motor Vehicle ......... 168 1 5/60 O&G Extraction Workers who drive at work ..... Hardcopy Version, Module 4: Motor Vehicle .... 19 1 5/60 Leroy A. Richardson, public health response activities, as well Management and Budget (OMB) for each Chief, Information Collection Review Office, as advance the scientific understanding collection of information they conduct Office of Scientific Integrity, Office of the of ZIKV illness and transmission. or sponsor. In addition, the PRA also Associate Director for Science, Office of the DATES: Written comments must be requires Federal agencies to provide a Director, Centers for Disease Control and received on or before June 5, 2017. 60-day notice in the Federal Register Prevention. concerning each proposed collection of ADDRESSES: You may submit comments, [FR Doc. 2017–06874 Filed 4–5–17; 8:45 am] information, including each new identified by Docket No. CDC–2017– BILLING CODE 4163–18–P 0030 by any of the following methods: proposed collection, each proposed • Federal eRulemaking Portal: extension of existing collection of Regulations.gov. Follow the instructions information, and each reinstatement of DEPARTMENT OF HEALTH AND previously approved information for submitting comments. HUMAN SERVICES • Mail: Leroy A. Richardson, collection before submitting the Centers for Disease Control and Information Collection Review Office, collection to OMB for approval. To Prevention Centers for Disease Control and comply with this requirement, we are Prevention, 1600 Clifton Road NE., MS– publishing this notice of a proposed [60Day–17–1140; Docket No. CDC–2017– D74, Atlanta, Georgia 30329. data collection as described below. 0030] Instructions: All submissions received Comments are invited on: (a) Whether must include the agency name and the proposed collection of information Proposed Data Collection Submitted Docket Number. All relevant comments is necessary for the proper performance for Public Comment and received will be posted without change of the functions of the agency, including Recommendations to Regulations.gov, including any whether the information shall have AGENCY: Centers for Disease Control and personal information provided. For practical utility; (b) the accuracy of the Prevention (CDC), Department of Health access to the docket to read background agency’s estimate of the burden of the and Human Services (HHS). documents or comments received, go to proposed collection of information; (c) Regulations.gov. ways to enhance the quality, utility, and ACTION: Notice with comment period. Please note: All public comment clarity of the information to be SUMMARY: The Centers for Disease should be submitted through the collected; (d) ways to minimize the Control and Prevention (CDC), as part of Federal eRulemaking portal burden of the collection of information its continuing efforts to reduce public (Regulations.gov) or by U.S. mail to the on respondents, including through the burden and maximize the utility of address listed above. use of automated collection techniques government information, invites the FOR FURTHER INFORMATION CONTACT: To or other forms of information general public and other Federal request more information on the technology; and (e) estimates of capital agencies to take this opportunity to proposed project or to obtain a copy of or start-up costs and costs of operation, comment on proposed and/or the information collection plan and maintenance, and purchase of services continuing information collections, as instruments, contact the Information to provide information. Burden means required by the Paperwork Reduction Collection Review Office, Centers for the total time, effort, or financial Act of 1995. This notice invites Disease Control and Prevention, 1600 resources expended by persons to mstockstill on DSK3G9T082PROD with NOTICES comment on Zika virus persistence in Clifton Road NE., MS–D74, Atlanta, generate, maintain, retain, disclose or body fluids of patients with Zika virus Georgia 30329; phone: 404–639–7570; provide information to or for a Federal infection in Puerto Rico (ZIPER Study) Email: omb@cdc.gov. agency. This includes the time needed to fill gaps in the scientific knowledge SUPPLEMENTARY INFORMATION: Under the to review instructions; to develop, base for ZIKV regarding the persistence Paperwork Reduction Act of 1995 (PRA) acquire, install and utilize technology and transmissibility of ZIKV in body (44 U.S.C. 3501–3520), Federal agencies and systems for the purpose of fluids. This information assist ongoing must obtain approval from the Office of collecting, validating and verifying VerDate Sep<11>2014 18:51 Apr 05, 2017 Jkt 241001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1

16838 Federal Register / Vol. 82, No. 65 / Thursday, April 6, 2017 / Notices information, processing and independent of their parents, are Since receipt of the initial OMB maintaining information, and disclosing pregnant, or have children). Individuals information collection approval in and providing information; to train with RT–PCR positive ZIKV infection October 2016, the project has enrolled personnel and to be able to respond to will be recruited through the Sentinel 295 Zika virus-infected individuals into a collection of information, to search Enhanced Dengue Surveillance System the Zika virus Persistence study, which data sources, to complete and review (SEDSS) at Saint Luke’s Episcopal are 55 individuals below the target the collection of information; and to Hospital in Ponce, Puerto Rico and enrollment of 350 individuals. transmit or otherwise disclose the through passive surveillance in selected Nonetheless, preliminary findings have information. municipalities in Puerto Rico. SEDSS been published in New England Journal was established in 2012 through a of Medicine, where we also expect that Proposed Project cooperative agreement between the the final report that includes the full Zika virus persistence in body fluids hospital in Consortium with the Ponce sample size will be published. of patients with Zika virus infection in School of Medicine and Ponce Research Puerto Rico (ZIPER Study)—Revision— This is a request to continue Institute from the Ponce Health Sciences information collection with minor National Center for Emerging and University and the CDC (Protocol Zoonotic Infectious Diseases (NCEZID), modifications. Modifications have been #6214). Specimens will be tested for the made to reflect the developing nature of Centers for Disease Control and presence of ZIKV ribonucleic acid Prevention (CDC). the science surrounding Zika virus (RNA) by RT–PCR at the CDC Dengue infection and potential outcomes Background and Brief Description Branch Laboratory in San Juan, and associated with infection, as well as positive specimens will be further tested CDC plans to seek a one-year OMB additional questions that were best for virus isolation to evaluate approval to extend information answered by taking advantage of the infectivity. Each body fluid will be collection covered under OMB Control existing study platform. Specifically, collected on a weekly basis for 4 weeks Number 0920–1140, expiration date 10/ CDC proposes the addition of two and biweekly thereafter until two 31/2017. components to the collection of data consecutive negative RT–PCR results are The Zika PERsistence (ZIPER) study under this study, one of which has obtained from all specimens. will help inform the presence and already begun: Irrespective of RNA detection, body duration of Zika virus (ZIKV) shedding fluids will also be collected for RT–PCT 1. A follow-up household visit has in several body fluids among RT–PCR– at 2, 4, and 6 months to investigate been added to determine how many positive ZIKV cases from Puerto Rico. It intermittent shedding. Analyses of household members of Zika virus- will also provide information regarding antibody response through titers of IgM infected participants become infected the duration of detection of anti-ZIKV and IgG will be performed at baseline during the 4 months following initial Immunoglobulin M (IgM) antibodies and repeated at 2, 4, and 6 months. screening. For any household members and the time for development of Among symptomatic participants seven that had no evidence of Zika virus Immunoglobulin G (IgG) antibodies milliliters (ml) of blood will be drawn infection at the initial visit, the same among the same population. In addition, at each study visit split into a tiger top questionnaires used at the initial this study will determine the prevalence of anti-ZIKV IgM and IgG, and virus tube (5ml) and a purple top tube (2ml) household visit will again be completed shedding in body fluids among for a total not to exceed 50 ml during ∼4 months later. Such information will household contacts of ZIKV cases. any given 8-week period. At enrollment provide additional information We propose to investigate the healthy non-pregnant adults will have regarding the incidence of Zika virus persistence (shedding) of ZIKV in 20 ml of blood collected following infections among households with a different body fluids and its relation to standard procedures. Two tiger top Zika-positive household member. immune response to provide a basis for tubes of 8.5 ml and one 3ml purple top 2. Additionally, CDC proposes development of non-blood-based tubes will be collected. These following up with men with Zika virus- diagnostic tools, and target and refine procedures will be repeated at each positive semen specimens to better public health interventions to arrest follow-up visit, see below. RT–PCR- understand the effect of Zika virus ongoing spread of infection. To do so, positive participants will be asked to infection on sperm. To do this, 8–14 we will conduct a prospective cohort refer up to 5 household members to semen ejaculates from 10–20 men study of individuals with reverse establish the percentage of household participating in the ZIPER study will be transcription-polymerase chain reaction members with detectable and used to determine the presence and/or (RT–PCR) positive ZIKV infection and a potentially infectious Zika virus RNA in detection of the Zika virus in different cross-sectional study of their household body fluids. Household members who fractions of the semen ejaculate (i.e., contacts. Results and analyses will be are found to be ZIKV RT–PCR-positive seminal plasma, cellular debris, used to update relevant counseling in any body fluid will be invited to including White Blood Cells [WBCs] messages and recommendations from participate in the cohort study. A and spermatozoa). CDC’s Institutional the CDC. second study visit will be scheduled Review Board (IRB) has approved this The study will include baseline and with household contact at 2 or 4 modification, but information collection follow-up questionnaires and the months, to detect new infections and has not begun. collection of the following specimens: estimate incidence. Because the original blood, saliva, urine from participants of study consent forms do not include this There is no cost to respondents other all ages, and semen/vaginal secretions visit, household contacts will be than the time to participate. mstockstill on DSK3G9T082PROD with NOTICES from adults (ages 21 years or older) and contacted by study staff and will be Authorizing legislation comes from legally emancipated minors (support consented again using the same consent Section 301 of the Public Health Service themselves financially, live form. Act (42 U.S.C. 241). VerDate Sep<11>2014 18:51 Apr 05, 2017 Jkt 241001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1

Federal Register / Vol. 82, No. 65 / Thursday, April 6, 2017 / Notices 16839 ESTIMATED ANNUALIZED BURDEN HOURS Average Number of Number of burden per Total burden Type of respondents Form name responses per respondents response (hrs) respondent (hrs) Public health personnel Shedding Questionnaire (Symptomatics) ............ 55 8 10/60 74 Shedding Questionnaire (Cross-Sectional 100 1 10/60 17 Asymptomatics). Questionnaire for men semen sub-study ............ 30 1 20/60 10 General public ............... Shedding Eligibility Form ..................................... 160 1 2/60 6 Contact Information Form .................................... 32 1 2/60 1 Total ....................... .............................................................................. ........................ ........................ ........................ 108 Leroy A. Richardson, DATES: Written comments must be collection before submitting the Chief, Information Collection Review Office, received on or before June 5, 2017. collection to OMB for approval. To Office of Scientific Integrity, Office of the ADDRESSES: You may submit comments, comply with this requirement, we are Associate Director for Science, Office of the identified by Docket No. CDC–2017– publishing this notice of a proposed Director, Centers for Disease Control and data collection as described below. Prevention. 0032 by any of the following methods: • Federal eRulemaking Portal: Comments are invited on: (a) Whether [FR Doc. 2017–06864 Filed 4–5–17; 8:45 am] Regulations.gov. Follow the instructions the proposed collection of information BILLING CODE 4163–18–P for submitting comments. is necessary for the proper performance • Mail: Leroy A. Richardson, of the functions of the agency, including Information Collection Review Office, whether the information shall have DEPARTMENT OF HEALTH AND Centers for Disease Control and practical utility; (b) the accuracy of the HUMAN SERVICES Prevention, 1600 Clifton Road NE., MS– agency’s estimate of the burden of the Centers for Disease Control and D74, Atlanta, Georgia 30329. proposed collection of information; (c) Prevention Instructions: All submissions received ways to enhance the quality, utility, and must include the agency name and clarity of the information to be [60Day–17–17ZX; Docket No. CDC–2017– Docket Number. All relevant comments collected; (d) ways to minimize the 0032] received will be posted without change burden of the collection of information to Regulations.gov, including any Proposed Data Collection Submitted on respondents, including through the personal information provided. For for Public Comment and use of automated collection techniques access to the docket to read background Recommendations or other forms of information documents or comments received, go to technology; and (e) estimates of capital Regulations.gov. AGENCY: Centers for Disease Control and or start-up costs and costs of operation, Please note: All public comment Prevention (CDC), Department of Health maintenance, and purchase of services should be submitted through the and Human Services (HHS). to provide information. Burden means Federal eRulemaking portal ACTION: Notice with comment period. (Regulations.gov) or by U.S. mail to the the total time, effort, or financial address listed above. resources expended by persons to SUMMARY: The Centers for Disease generate, maintain, retain, disclose or Control and Prevention (CDC), as part of FOR FURTHER INFORMATION CONTACT: To provide information to or for a Federal its continuing efforts to reduce public request more information on the agency. This includes the time needed burden and maximize the utility of proposed project or to obtain a copy of to review instructions; to develop, government information, invites the the information collection plan and instruments, contact the Information acquire, install and utilize technology general public and other Federal and systems for the purpose of agencies to take this opportunity to Collection Review Office, Centers for Disease Control and Prevention, 1600 collecting, validating and verifying comment on proposed and/or information, processing and continuing information collections, as Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; maintaining information, and disclosing required by the Paperwork Reduction and providing information; to train Act of 1995. This notice invites Email: omb@cdc.gov. personnel and to be able to respond to comment on ‘‘Childhood Blood Lead SUPPLEMENTARY INFORMATION: Under the a collection of information, to search Surveillance (CBLS) and Adult Blood Paperwork Reduction Act of 1995 (PRA) data sources, to complete and review Lead Epidemiology and Surveillance (44 U.S.C. 3501–3520), Federal agencies the collection of information; and to (ABLES).’’ The National Center for must obtain approval from the Office of transmit or otherwise disclose the Environmental Health (NCEH) is leading Management and Budget (OMB) for each a new three-year information collection collection of information they conduct information. request (ICR) that covers two CDC or sponsor. In addition, the PRA also Proposed Project information collections, one for requires Federal agencies to provide a mstockstill on DSK3G9T082PROD with NOTICES childhood blood lead surveillance by 60-day notice in the Federal Register Childhood Blood Lead Surveillance NCEH and another for adult blood lead concerning each proposed collection of (CBLS) and Adult Blood Lead surveillance by the National Institute for information, including each new Epidemiology and Surveillance Occupational Safety and Health proposed collection, each proposed (ABLES)—New—National Center for (NIOSH). CDC requests an annual time extension of existing collection of Environmental Health (NCEH), Centers burden of 1,120 burden hours for both information, and each reinstatement of for Disease Control and Prevention collections. previously approved information (CDC). VerDate Sep<11>2014 18:51 Apr 05, 2017 Jkt 241001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1


Document Created: 2017-04-06 01:46:36
Document Modified: 2017-04-06 01:46:36
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before June 5, 2017.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation82 FR 16837 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR